No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Chart series for revenue are being prepared.
No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Chart series for revenue are being prepared.
The latest delayed quote for Conexeu Sciences Inc. (CNXU) stock was $3.23 as of Oct 6, 2026, 10:10 AM EDT, up 3.53% from the previous close.
Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine.
Biotechnology · Reno, NV
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
$-0.29
vs Estimate
$-0.10
Revenue
N/A
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1CNXU | $86.43M | $3.23 | +3.53% | N/A | N/A | N/A | N/A |
| 2CGTX | $85.90M | $0.96 | +2.31% | -39.33% | N/A | N/A | vs CNXU |
| 3CRDF | $87.48M | $1.14 | -0.44% | -47.78% | -30.36% | -43.20% | vs CNXU |
| 4CCLD | $87.75M | $2.06 | +1.23% | -39.68% | -23.18% | +8.53% | vs CNXU |
| 5HUMA | $84.87M | $0.51 | +1.04% | -76.03% | -45.73% | N/A | vs CNXU |
| 6ACRV | $84.75M | $1.98 | +0.00% | +3.65% | N/A | N/A | vs CNXU |
forward FY estimate
N/A
vs Estimate
N/A
Consensus Rating
Based on 1 analyst
Average Price Target
$20.00
+519.2% upside
Low
$20.00
Current
$3.23
High
$20.00